These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33676450)

  • 21. Succinate dehydrogenase deficiency in a PDGFRA mutated GIST.
    Belinsky MG; Cai KQ; Zhou Y; Luo B; Pei J; Rink L; von Mehren M
    BMC Cancer; 2017 Aug; 17(1):512. PubMed ID: 28768491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of Liquid Biopsies into Clinical Laboratory Applications via NGS in Cancer Diagnostics.
    Sonmezler O; Boga I; Bisgin A
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct next-generation sequencing analysis using endometrial liquid-based cytology specimens for rapid cancer genomic profiling.
    Akahane T; Kitazono I; Kobayashi Y; Nishida-Kirita Y; Yamaguchi T; Yanazume S; Tabata K; Kobayashi H; Tanimoto A
    Diagn Cytopathol; 2021 Sep; 49(9):1078-1085. PubMed ID: 34319014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germ-line mutations in nonsyndromic pheochromocytoma.
    Neumann HP; Bausch B; McWhinney SR; Bender BU; Gimm O; Franke G; Schipper J; Klisch J; Altehoefer C; Zerres K; Januszewicz A; Eng C; Smith WM; Munk R; Manz T; Glaesker S; Apel TW; Treier M; Reineke M; Walz MK; Hoang-Vu C; Brauckhoff M; Klein-Franke A; Klose P; Schmidt H; Maier-Woelfle M; Peçzkowska M; Szmigielski C; Eng C;
    N Engl J Med; 2002 May; 346(19):1459-66. PubMed ID: 12000816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing.
    Pantaleo MA; Astolfi A; Indio V; Moore R; Thiessen N; Heinrich MC; Gnocchi C; Santini D; Catena F; Formica S; Martelli PL; Casadio R; Pession A; Biasco G
    J Natl Cancer Inst; 2011 Jun; 103(12):983-7. PubMed ID: 21505157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline variants in familial pituitary tumour syndrome genes are common in young patients and families with additional endocrine tumours.
    De Sousa SMC; McCabe MJ; Wu K; Roscioli T; Gayevskiy V; Brook K; Rawlings L; Scott HS; Thompson TJ; Earls P; Gill AJ; Cowley MJ; Dinger ME; McCormack AI
    Eur J Endocrinol; 2017 May; 176(5):635-644. PubMed ID: 28220018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cousins not twins: intratumoural and intertumoural heterogeneity in syndromic neuroendocrine tumours.
    Flynn A; Dwight T; Benn D; Deb S; Colebatch AJ; Fox S; Harris J; Duncan EL; Robinson B; Hogg A; Ellul J; To H; Duong C; Miller JA; Yates C; James P; Trainer A; Gill AJ; Clifton-Bligh R; Hicks RJ; Tothill RW
    J Pathol; 2017 Jul; 242(3):273-283. PubMed ID: 28369925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amplicon-Based NGS Panels for Actionable Cancer Target Identification in Follicular Cell-Derived Thyroid Neoplasia.
    Madsen MB; Kiss K; Cilius Nielsen F; Bennedbæk FN; Rossing M
    Front Endocrinol (Lausanne); 2020; 11():146. PubMed ID: 32265839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic alterations in circulating cell-free DNA of oesophageal carcinoma patients during primary staging are indicative for post-surgical tumour recurrence.
    Pasternack H; Fassunke J; Plum PS; Chon SH; Hescheler DA; Gassa A; Merkelbach-Bruse S; Bruns CJ; Perner S; Hallek M; Büttner R; Bollschweiler E; Hölscher AH; Quaas A; Zander T; Weiss J; Alakus H
    Sci Rep; 2018 Oct; 8(1):14941. PubMed ID: 30297788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential Pitfalls of SDH Immunohistochemical Detection in Paragangliomas and Phaeochromocytomas Harbouring Germline
    Santi R; Rapizzi E; Canu L; Ercolino T; Baroni G; Fucci R; Costa G; Mannelli M; Nesi G
    Anticancer Res; 2017 Feb; 37(2):805-812. PubMed ID: 28179334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-depth sequencing of paired primary and metastatic tumours: Implications for personalised medicine.
    Grellety T; Lucchesi C; Hostein I; Auzanneau C; Khalifa E; Soubeyran I; Italiano A
    Eur J Cancer; 2017 Oct; 84():250-256. PubMed ID: 28841542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of succinate dehydrogenase subunit protein in succinate dehydrogenase-deficient gastrointestinal stromal tumors].
    Zhang YJ; Cheng YH; Guo LX; Wang NQ; Liu H
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):252-257. PubMed ID: 29690663
    [No Abstract]   [Full Text] [Related]  

  • 33. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
    Andersson C; Fagman H; Hansson M; Enlund F
    Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy.
    von Baumgarten L; Kumbrink J; Jung A; Reischer A; Flach M; Liebmann S; Metzeler KH; Holch JW; Niyazi M; Thon N; Straube A; von Bergwelt-Baildon M; Heinemann V; Kirchner T; Westphalen CB
    Theranostics; 2020; 10(2):856-866. PubMed ID: 31903155
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical genetics of neuroendocrine tumors].
    Karges W; Adler G
    Med Klin (Munich); 2003 Dec; 98(12):712-6. PubMed ID: 14685672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing.
    Guo Q; Wang J; Xiao J; Wang L; Hu X; Yu W; Song G; Lou J; Chen J
    Mol Cancer; 2018 Aug; 17(1):131. PubMed ID: 30153823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours.
    Samsom KG; Levy S; van Veenendaal LM; Roepman P; Kodach LL; Steeghs N; Valk GD; Wouter Dercksen M; Kuhlmann KFD; Verbeek WHM; Meijer GA; Tesselaar MET; van den Berg JG
    Histopathology; 2021 Mar; 78(4):556-566. PubMed ID: 32931025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing.
    Backman S; Norlén O; Eriksson B; Skogseid B; Stålberg P; Crona J
    Anticancer Res; 2017 Feb; 37(2):705-712. PubMed ID: 28179320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relevance of neuroendocrine tumours models assessed by kinomic profiling.
    Romano D
    Ann Endocrinol (Paris); 2019 Jun; 80(3):144-148. PubMed ID: 31054767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
    Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.